NKTR Return on Tangible Equity | Nektar Therapeutics

Nektar Therapeutics (NKTR) Return on Tangible Equity

2026-06-30: Return Tang Equity -17.40%.
2026-03-31: Return Tang Equity -27.44%.
2025-12-31: Return Tang Equity -182.65%.
2025-09-30: Return Tang Equity -141.90%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-17.40%
2026-03-31	-27.44%
2025-12-31	-182.65%
2025-09-30	-141.90%
2025-06-30	505.02%
2025-03-31	-968.42%
2024-12-31	-195.86%
2024-09-30	-344.29%
2024-06-30	-222.22%
2024-03-31	-138.78%
2023-12-31	-210.75%
2023-09-30	-184.27%
2023-06-30	-155.81%
2023-03-31	-172.22%
2022-12-31	-126.90%
2022-09-30	-135.28%
2022-06-30	-137.30%
2022-03-31	-92.45%
2021-12-31	-86.87%
2021-09-30	-68.33%
2021-06-30	-57.25%
2021-03-31	-46.71%
2020-12-31	-44.41%
2020-09-30	-40.15%
2020-06-30	-36.40%
2020-03-31	-37.68%
2019-12-31	-33.16%
2019-09-30	-30.22%
2019-06-30	-28.65%
2019-03-31	42.23%
2018-12-31	41.52%
2018-09-30	43.52%
2018-06-30	50.60%
2018-03-31	705.99%
2017-12-31	-853.64%
2017-09-30	-1371.43%
2017-06-30	286.07%
2017-03-31	623.24%
2016-12-31	-1320.75%
2016-09-30	114.62%
2016-06-30	112.69%
2016-03-31	175.18%
2015-12-31	115.85%
2015-09-30	194.20%
2015-06-30	-14.70%
2015-03-31	3246.89%
2014-12-31	134.22%
2014-09-30	190.87%
2014-06-30	127.87%
2014-03-31	177.44%
2013-12-31	97.36%
2013-09-30	131.98%
2013-06-30	165.98%
2013-03-31	234.86%
2012-12-31	582.90%
2012-09-30	-830.67%
2012-06-30	-245.50%
2012-03-31	-161.70%
2011-12-31	-110.44%
2011-09-30	-77.17%
2011-06-30	-59.34%
2011-03-31	-33.14%
2010-12-31	-267.90%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-182.65%
2024-12-31	-195.86%
2023-12-31	-210.75%
2022-12-31	-126.90%
2021-12-31	-86.87%
2020-12-31	-44.41%
2019-12-31	-33.16%
2018-12-31	41.52%
2017-12-31	-853.64%
2016-12-31	-1320.75%
2015-12-31	115.85%
2014-12-31	134.22%
2013-12-31	97.36%
2012-12-31	582.90%
2011-12-31	-110.44%
2010-12-31	-267.90%
2009-12-31	-100.15%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
UroGen Pharma Ltd. (URGN)		$2.015B	-18.42
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
Nuvation Bio Inc. (NUVB)	United States	$2.007B	-13.12
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)	United States	$1.962B	-5.38
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89